Stock data
ImmuCell Corporation (ICCC)
ImmuCell Corporation (ICCC) reported revenue of US$27.64M and net income of -US$1.04M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$27.64M | US$11.45M | US$1.65M | -US$1.04M | — |
| 2024 | US$26.49M | US$7.94M | -US$1.64M | -US$2.16M | — |
| 2023 | US$17.47M | US$3.87M | -US$5.75M | -US$5.77M | — |
| 2022 | US$18.57M | US$7.65M | -US$2.30M | -US$2.49M | — |
| 2021 | — | US$8.66M | US$0.26M | -US$0.08M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$7.19M | US$1.83M | — |
| 2026-03-31 | US$10.36M | US$1.94M | — |
| 2025-12-31 | US$7.63M | -US$2.85M | — |
| 2025-09-30 | US$5.51M | -US$0.14M | — |
| 2025-06-30 | US$6.44M | US$0.50M | — |
| 2025-03-31 | US$8.07M | US$1.45M | — |
| 2024-12-31 | US$7.75M | US$0.51M | — |
| 2024-09-30 | US$6.01M | -US$0.70M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.